Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities
M. Koennecke, Ludger Klimek, Joaquim Mullol, et al.
Allergo Journal International (2018) Vol. 27, Iss. 2, pp. 56-65
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
Philippe Gevaert, Theodore A. Omachi, Jonathan Corren, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 3, pp. 595-605
Open Access | Times Cited: 530
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
Tanya M. Laidlaw, Claus Bachert, Nikhil Amin, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 126, Iss. 5, pp. 584-592.e1
Open Access | Times Cited: 85
Inflammation and Endotyping in Chronic Rhinosinusitis—A Paradigm Shift
Sinead Ahern, Anders Cervin
Medicina (2019) Vol. 55, Iss. 4, pp. 95-95
Open Access | Times Cited: 81
Real-Life Effectiveness of Mepolizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps
María Sandra Domínguez-Sosa, María Soledad Cabrera-Ramírez, Miriam del Carmen Marrero-Ramos, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 485-485
Open Access | Times Cited: 32
Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic—An EAACI position paper
Ludger Klimek, Marek Jutel, Jean Bousquet, et al.
Allergy (2020) Vol. 76, Iss. 3, pp. 677-688
Open Access | Times Cited: 62
Surgery in Nasal Polyp Patients: Outcome After a Minimum Observation of 10 Years
Stephan Vlaminck, Frederic Acke, Emmanuel P. Prokopakis, et al.
American Journal of Rhinology and Allergy (2020) Vol. 35, Iss. 4, pp. 449-457
Closed Access | Times Cited: 42
Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup Analysis
Cecelia Damask, Meng Chen, Cécile Holweg, et al.
American Journal of Rhinology and Allergy (2021) Vol. 36, Iss. 1, pp. 135-141
Closed Access | Times Cited: 40
Nasal Polyposis: Insights in Epithelial-Mesenchymal Transition and Differentiation of Polyp Mesenchymal Stem Cells
Emanuela Chiarella, Nicola Lombardo, Nadia Lobello, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6878-6878
Open Access | Times Cited: 35
Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with Dupilumab
Zeynep Danisman, Maximilian Linxweiler, Jan Philipp Kühn, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Allergologie select (2024) Vol. 8, Iss. 1, pp. 26-39
Open Access | Times Cited: 3
The Role of Epigenetics in the Chronic Sinusitis with Nasal Polyp
Tiancong Liu, Yang Sun, Weiliang Bai
Current Allergy and Asthma Reports (2020) Vol. 21, Iss. 1
Closed Access | Times Cited: 26
Positionspapier: Anwendung von Biologika bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)
Ludger Klimek, Ulrike Förster‐Ruhrmann, Sven Becker, et al.
Laryngo-Rhino-Otologie (2020) Vol. 99, Iss. 08, pp. 511-527
Open Access | Times Cited: 26
Type 2 immunity‐driven diseases: Towards a multidisciplinary approach
D. Hassoun, O. Malard, S. Barbarot, et al.
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 12, pp. 1538-1552
Open Access | Times Cited: 23
Positionspapier: Empfehlungen zur Anwendung von Omalizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)
Ludger Klimek, Ulrike Förster‐Ruhrmann, Achim Beule, et al.
Laryngo-Rhino-Otologie (2021) Vol. 100, Iss. 12, pp. 952-963
Closed Access | Times Cited: 22
Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP)
Ludger Klimek, Ulrike Förster‐Ruhrmann, Achim Beule, et al.
Allergo Journal International (2022) Vol. 31, Iss. 6, pp. 149-160
Open Access | Times Cited: 14
Defining the Allergic Endotype of Chronic Rhinosinusitis by Structured Histopathology and Clinical Variables
Hannah J. Brown, Bobby A. Tajudeen, Hannah N. Kuhar, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 10, pp. 3797-3804
Open Access | Times Cited: 19
Deficit in Adipose Differentiation in Mesenchymal Stem Cells Derived from Chronic Rhinosinusitis Nasal Polyps Compared to Nasal Mucosal Tissue
Emanuela Chiarella, Nicola Lombardo, Nadia Lobello, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9214-9214
Open Access | Times Cited: 20
Clinical Assessment of Chronic Rhinosinusitis
Claire Hopkins, Stella E. Lee, Ludger Klimek, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1406-1416
Closed Access | Times Cited: 12
Cellular and Biochemical Characterization of Mesenchymal Stem Cells from Killian Nasal Polyp
Maria Mesuraca, Clelia Nisticò, Nicola Lombardo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13214-13214
Open Access | Times Cited: 11
Current goals of NSAID-ERD management: patient-centered approaches involving NSAID desensitization with and without biologics
Irina Bobolea, Jan Hagemann, Marek Sanak, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2934-2944
Open Access | Times Cited: 2
Immunologie der Polyposis nasi als Grundlage für eine Therapie mit Biologicals
Ludger Klimek, M. Koennecke, Jan Hagemann, et al.
HNO (2018) Vol. 67, Iss. 1, pp. 15-26
Closed Access | Times Cited: 20
Nasal Polyposis: Insights in Epithelial-mesenchymal Transition and Differentiation of Polyp Mesenchymal Stem Cells
Emanuela Chiarella, Nicola Lombardo, Nadia Lobello, et al.
(2020)
Open Access | Times Cited: 15
Biologics for chronic rhinosinusitis with nasal polyps: Economics and ethics
Lauren T. Roland, Alan Regenberg, Amber Luong, et al.
International Forum of Allergy & Rhinology (2021) Vol. 11, Iss. 11, pp. 1524-1528
Closed Access | Times Cited: 13
Positionspapier: Empfehlungen zur Anwendung von Mepolizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie (DGHNO-KHC)
Ludger Klimek, Heidi Olze, Ulrike Förster‐Ruhrmann, et al.
Laryngo-Rhino-Otologie (2022) Vol. 101, Iss. 04, pp. 284-294
Closed Access | Times Cited: 9
Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP)
Ludger Klimek, Jan Hagemann, Hans‐Jürgen Welkoborsky, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 148-166
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top